{"id":150923,"date":"2014-10-16T05:46:06","date_gmt":"2014-10-16T09:46:06","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/new-guideline-in-genetic-testing-for-certain-types-of-muscular-dystrophy.php"},"modified":"2014-10-16T05:46:06","modified_gmt":"2014-10-16T09:46:06","slug":"new-guideline-in-genetic-testing-for-certain-types-of-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/new-guideline-in-genetic-testing-for-certain-types-of-muscular-dystrophy.php","title":{"rendered":"New guideline in genetic testing for certain types of muscular dystrophy"},"content":{"rendered":"<p><p>    PUBLIC RELEASE DATE:  <\/p>\n<p>    15-Oct-2014  <\/p>\n<p>    Contact: Duska Anastasijevic    <a href=\"mailto:newsbureau@mayo.edu\">newsbureau@mayo.edu<\/a>    507-284-5005    Mayo Clinic    @MayoClinic<\/p>\n<p>    Rochester, Minn.  The American Academy of Neurology (AAN) and    the American Association of Neuromuscular &    Electrodiagnostic Medicine (AANEM) offer a new guideline on how    to determine what genetic tests may best diagnose a person's    subtype of limb-girdle or distal muscular dystrophy. The    guideline is published in the October 14, 2014, print issue of    Neurology, the medical journal of the AAN.  <\/p>\n<p>    Researchers reviewed all of the available studies on the    muscular dystrophy, a group of genetic diseases in which muscle    fibers are unusually susceptible to damage, as part of the    process in developing the new guideline.  <\/p>\n<p>    Doctors should conduct a thorough evaluation of symptoms,    family history, ethnicity, and results of physical exam and    certain lab tests to determine what genetic tests may be more    appropriate to order.  <\/p>\n<p>    \"The guideline should help physicians arrive at the right    diagnosis quicker so patients will not need to take unnecessary    test\", says Mayo Clinic neurologist Duygu Selcen, M.D., who was    part of the multi-center research team led by Julie Bolen, PhD,    MPH, from the National Center on Birth Defects and    Developmental Disabilities, at the Centers for Disease Control    and Prevention (CDC). \"This is particularly important because    the muscle diseases are often hard to diagnose\", adds Dr.    Selcen.  <\/p>\n<p>    There are several known subtypes of limbgirdle muscular    dystrophy and distal muscular dystrophy. Experts continue to    discover new subtypes and the guidance should help shorten the    time to the right treatment.  <\/p>\n<p>    While there is no cure for these disorders, complications can    be managed. The guideline makes recommendations about treating    and managing complications, which may include muscle symptoms,    heart problems and breathing problems.  <\/p>\n<p>    The guideline recommends that care for people with these    disorders should be coordinated through treatment centers    specializing in muscular dystrophy. People with these disorders    should tell their doctors about any symptoms such as the heart    beating too fast or skipping beats, shortness of breath and    pain or difficulty in swallowing, as treatments may be    available. People should also talk to their doctors about    exercises that are safe.  <\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/www.eurekalert.org\/pub_releases\/2014-10\/mc-ngi101514.php\/RK=0\/RS=KhE2IzBuZsy.YyrwMjpcThqkjWI-\" title=\"New guideline in genetic testing for certain types of muscular dystrophy\">New guideline in genetic testing for certain types of muscular dystrophy<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> PUBLIC RELEASE DATE: 15-Oct-2014 Contact: Duska Anastasijevic <a href=\"mailto:newsbureau@mayo.edu\">newsbureau@mayo.edu<\/a> 507-284-5005 Mayo Clinic @MayoClinic Rochester, Minn.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/genetic-medicine\/new-guideline-in-genetic-testing-for-certain-types-of-muscular-dystrophy.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[5],"tags":[],"class_list":["post-150923","post","type-post","status-publish","format-standard","hentry","category-genetic-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/150923"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=150923"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/150923\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=150923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=150923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=150923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}